JPS6013004B2 - Production method of interferon inducer - Google Patents

Production method of interferon inducer

Info

Publication number
JPS6013004B2
JPS6013004B2 JP55107955A JP10795580A JPS6013004B2 JP S6013004 B2 JPS6013004 B2 JP S6013004B2 JP 55107955 A JP55107955 A JP 55107955A JP 10795580 A JP10795580 A JP 10795580A JP S6013004 B2 JPS6013004 B2 JP S6013004B2
Authority
JP
Japan
Prior art keywords
active substance
seeds
extract
water
safflower
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP55107955A
Other languages
Japanese (ja)
Other versions
JPS5732223A (en
Inventor
保彦 小島
精之 金野
喬 橋本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KITAZATO KENKYUSHO
Original Assignee
KITAZATO KENKYUSHO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KITAZATO KENKYUSHO filed Critical KITAZATO KENKYUSHO
Priority to JP55107955A priority Critical patent/JPS6013004B2/en
Priority to GB8123976A priority patent/GB2082187B/en
Priority to US06/290,283 priority patent/US4440761A/en
Publication of JPS5732223A publication Critical patent/JPS5732223A/en
Publication of JPS6013004B2 publication Critical patent/JPS6013004B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Description

【発明の詳細な説明】 本発明はインターフェロン(以下IFという)誘起剤の
製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing an interferon (hereinafter referred to as IF) inducer.

さきに本発明者はキク科(Compositae)ベニ
バナ属(Canhamus)に属しかつインターフェロ
ン誘起活性物質を含有する植物またはその変員の組織か
ら上記活性物質を抽出し、抽出物からこれを回収する工
程によって、優れたIF誘起活性と極めて低い毒性とを
有するIF誘起剤(以下活性物質Aという)を製造し得
ることを見出したく特許藤昭54一13024号、同昭
弘−170641号参照)。さらに活性物質Aがヒトお
よび動物の腫湯に対して優れた阻止活性を有するばかり
でなく、生理作用を改善する効果を有することを見出し
た(特許願昭和50王8月6日出機)。活性物質Aの製
造原料とされる植物は、世界各国に豊富に裁培または自
生し、自然または人工的に突然変異体や雑種のような変
員(variant)を形成する鏡向がある。
First, the present inventors extracted the active substance from the tissue of a plant belonging to the Compositae family, the genus Canhamus and containing an interferon-inducing active substance or its variants, and recovered the active substance from the extract. (See Japanese Patents No. 54-13024 and Akihiro-170641) to discover that it is possible to produce an IF inducer (hereinafter referred to as active substance A) having excellent IF-inducing activity and extremely low toxicity. Furthermore, it has been found that active substance A not only has an excellent inhibitory activity against tumours in humans and animals, but also has the effect of improving physiological effects (patent application filed on August 6, 1975). Plants that are used as raw materials for the production of active substance A are abundantly cultivated or grow naturally in various countries around the world, and there are varieties that naturally or artificially form variants such as mutants and hybrids.

各国の多くのベニバナ属植物およびそれらの変員を活性
物質Aの製造に用いることができる。下記の植物は例示
にすぎない。ベニバナ(Canhamustincのr
i瓜Linne),アレチベニバナ(Caれham瓜
la雌t雌 Lin船),Canham瓜 arbor
eSCe船 Linne , CanhamuS舷et
jc雌Nのman.またはこれらの変員。
Many plants of the genus Safflower and their variants can be used for the preparation of active substance A from many countries. The plants listed below are illustrative only. Safflower (Canhamustinc r)
Linne)
La female T female Lin ship), Canham melon arbor
eSCe ship Linne, CanhamuS side
jc female N man. Or these variables.

活性物質Aは水とくにアルカリ性水溶液によく溶けるの
で、原料植物から活性物質Aを水で抽出する。または親
水性有機溶剤で抽出することもできる。活性物質Aの分
子量は約10万以上約300方以下(主として約50万
以上約100方以下)であるから、たとえば、分画分子
量10万以上の物質を分別できる適当な膜を用いた限外
炉過法で、抽出液の上燈液を処理することによって、活
性物質Aを抽出液から回収することができる。または抽
出液を所望により濃縮した後、親水性有機溶剤を加える
と、活性成分を含む沈殿物が生じるので、これから活性
物質Aを回収することができる。あるいは、親水性有機
溶剤の代り1こ、適当なアンモニウム塩または無機金属
塩を用いてもよい。活性物質Aは水溶性の酸性物質であ
るから、この種の物質の精製に常用される各種の精製法
(たとえばゲル炉過剤やイオン交換剤を用いるカラムク
ロマトグラフィー)によって、回収された粗活性物質A
を精製することができる。上記活性物質Aは、ベニバナ
属植物またはその変員の組織のうち、花に最も多く含有
されているので、活性物質Aの製造原料は、実用的には
、花である。さて、その後の研究の結果、これらの植物
またはその変員の種子に、活性物質Aと同等以上の譲超
活性を有する別の活性物質(以下活性物質Bという)が
多量に含有されていること、および活性物質Aの製造方
法と類似の方法によって活性物質Bを簡単に安価に製造
し得ることが分った。活性物質Bの理化学的特性はまだ
充分に解明されるに至らないが、活性物質Aの分子量(
約10方以上約300方以下、主として約50万以上約
100万以下)とは異なる分子量(約1万以上約20方
、主として約2万一約8方)を有する点および活性物質
Bは種子に、また活性物質Aは花に主として含有されて
いる点からみて、両者は明らかに異なる物質であると考
えられる。従って本発明の目的は、キク料ベニバナ属に
属する植物またはその変員から単離されたm誘起剤の製
造方法を提供することにある。
Since the active substance A is highly soluble in water, particularly in an alkaline aqueous solution, the active substance A is extracted from the raw material plant with water. Alternatively, it can also be extracted with a hydrophilic organic solvent. Since the molecular weight of the active substance A is about 100,000 to about 300 (mainly about 500,000 to about 100), for example, ultraviolet rays using an appropriate membrane that can separate substances with a cutoff molecular weight of 100,000 or more can be used. The active substance A can be recovered from the extract by treating the supernatant of the extract using a filtration method. Alternatively, if the extract is concentrated as desired and then a hydrophilic organic solvent is added, a precipitate containing the active ingredient is generated, from which the active substance A can be recovered. Alternatively, a suitable ammonium salt or inorganic metal salt may be used instead of the hydrophilic organic solvent. Since active substance A is a water-soluble acidic substance, the crude active substance recovered by various purification methods commonly used for the purification of this type of substance (for example, column chromatography using a gel furnace filtration agent or an ion exchange agent) Substance A
can be purified. The active substance A is contained in the largest amount in flowers among the tissues of plants of the genus Safflower or its variants, so the raw material for producing the active substance A is practically flowers. Now, as a result of subsequent research, it has been found that the seeds of these plants or their variants contain a large amount of another active substance (hereinafter referred to as active substance B) that has a superactivity equal to or higher than that of active substance A. It has been found that active substance B can be produced easily and inexpensively by a method similar to that of , and active substance A. Although the physical and chemical properties of active substance B have not yet been fully elucidated, the molecular weight of active substance A (
Active substance B has a different molecular weight (about 10,000 to about 20, mainly about 20,001 to about 8) from the seed In addition, since active substance A is mainly contained in flowers, the two are considered to be clearly different substances. Accordingly, an object of the present invention is to provide a method for producing an m-inducing agent isolated from a plant belonging to the genus Safflower or its variants.

本発明により提供されるIF誘起剤の製造方法は、キク
科(Compositae)ベニバナ属(Canham
雌)またはその変員に属しかつIF誘起活性物質を含有
する植物の組織から、上記活性物質を抽出し、抽出物か
らこれを回収する工程からなり、組織として種子を用い
ることを特徴としている。
The method for producing an IF inducer provided by the present invention is directed to
This method consists of the steps of extracting the above-mentioned active substance from the tissue of a plant belonging to the female (Female) or its mutants and containing the IF-inducing active substance, and recovering it from the extract, and is characterized by using seeds as the tissue.

本発明により、分子量約1万なし、し約20万、主とし
て約2方から約8万までの抽出物区分から活性物質を回
収する。
According to the invention, active substances are recovered from extract fractions with molecular weights from about 10,000 to about 200,000, primarily from about 2 to about 80,000.

本発明の方法は、活性物質Aの製造方法と類似であるが
、活性物質Bおよび種子特有の理化学的性状に対応する
ために変形されているので、活性物質Aの製造方法と同
一ではない。
The method of the present invention is similar to the method for producing active substance A, but is not the same as the method for producing active substance A, since it has been modified to accommodate the unique physical and chemical properties of active substance B and seeds.

本発明の方法により、活性物質Aと同等以上のIF誘起
活性を有するび誘起剤を簡単に安価に製造することがで
きる。次に本発明の方法を詳しく説明する。
By the method of the present invention, an inducer having an IF-inducing activity equivalent to or higher than that of active substance A can be produced easily and inexpensively. Next, the method of the present invention will be explained in detail.

原料 ベニバナ属植物またはその変員の種子であって、IF譲
起活性物質を含有するものを原料として用いることがで
きる。
Raw materials Seeds of plants of the genus Safflower or their variants, which contain an IF-inducing active substance, can be used as raw materials.

実質的には上記に例示した植物の種子が用いられるが、
とくに有利なのはベニバナの種子である。ベニバナはべ
ニの原料、食料、飼料、薬草等として有用な植物で、古
くから世界各国で広く栽培されている。ベニバナの種子
は各国で食用油原料とされている。これに対して、従来
提案された各種の公知のIF譲起剤の場合、最も重要な
欠点は、高い毒性を有する点である。次に、たとえばベ
ニバナの種子は採油原料として工業的に利用されている
が、処理された種子の油律の用途(飼料等)は、いわば
原始的である。従って本発明の方法に用いられる量の原
料を安価確実に入手することは容易である。原料は新鮮
な種子でもよいが保存および抽出効率上、乾燥した種子
を用いると有利である。
Substantially, the seeds of the plants exemplified above are used, but
Particularly advantageous are safflower seeds. Safflower is a plant that is useful as a raw material, food, feed, medicinal herb, etc., and has been widely cultivated in countries around the world since ancient times. Safflower seeds are used as a raw material for edible oil in many countries. On the other hand, the most important drawback of the various known IF enhancers proposed so far is that they have high toxicity. Next, for example, safflower seeds are used industrially as a raw material for oil extraction, but the oil-based uses (for feed, etc.) of treated seeds are, so to speak, primitive. Therefore, it is easy to obtain raw materials in the quantities used in the method of the present invention at low cost and reliably. Although fresh seeds may be used as the raw material, it is advantageous to use dried seeds in terms of storage and extraction efficiency.

種子は固い外種皮とその内容物からなり、本活性物質は
どちらにも含まれている。抽出前に種子を破砕すると抽
出効率を高めることができる。
Seeds consist of a hard outer seed coat and its contents, both of which contain the active substance. Crushing the seeds before extraction can increase extraction efficiency.

従って、採油後の種子の油粕を原料として用いるのは良
い方法である。とくにベニバナの種子は多量の油脂を含
んでいるが、サフラワー油採取の常法(たとえばホット
プレス法、有機溶剤抽出法等)で処理された種子、(た
とえば常法により、スクリュープレスで処理後、ヘキサ
ンで抽出したべニハナ種子の油粕は通常約1%の油脂を
含み、飼料とされている。)を、本発明の方法の良好な
原料として用いることができる。種子から活性物質を抽
出する前に有機溶剤で脱脂した場合と、脱脂しない場合
とを比較すると、本活性物質の収量およびIF誘起活性
は著しい差が認められないことがわかった。抽出 水で抽出することは安価で実用的な方法である。
Therefore, it is a good method to use oil cake from seeds after oil extraction as a raw material. In particular, safflower seeds contain a large amount of oil and fat, but seeds that have been processed using conventional methods for extracting safflower oil (e.g., hot press method, organic solvent extraction method, etc.), seeds that have been processed using conventional methods (for example, screw press), The oil cake of safflower seeds extracted with hexane usually contains about 1% fat and oil and is used as feed) can be used as a good raw material for the method of the present invention. When comparing the case where the active substance was defatted with an organic solvent before extracting the active substance from the seeds and the case where it was not defatted, it was found that there was no significant difference in the yield of the active substance and the IF-inducing activity. Extraction with extraction water is an inexpensive and practical method.

水を用いる抽出は任意温度(たとえば室温から約130
qoまで)で行なうことができる。本発明による物質は
アルカリ性の水溶液(例、風7一10)によく溶けるの
で、公知の緩衝液や水酸化ナトリウム、水酸化カリウム
、水酸化アンモニウム等を用いて、抽出時に水のpHを
調整するとよい。抽出時間は任意であるが、室温では通
常1一5日である。抽出温度が高いと抽出時間は短縮さ
れる(たとえば40一120つ0で30分から6時間)
。これによって、種子に含まれた活性成分の大部分(場
合により90%以上)を抽出することができる。所望に
より、抽出時に適当な防腐剤を加えることもできる。抽
出は連続式でもバッチ式でもよい。抽出水と原料との比
は任意である。(例えば原料の5一1の音量)。所望に
より、適当な有機溶剤(例、メタノール、エタノール、
クロロホルム、エーテル、ヘキサンの1種または混合液
)で種子に含まれた脂質のような不純物を除去した後で
水で抽出すると容易に目的産物を抽出することができ、
しかも活性物質は矢なわれない。
Extraction with water can be carried out at any temperature (e.g. from room temperature to about 130°C).
up to qo). Since the substance according to the present invention is highly soluble in alkaline aqueous solutions (e.g., Kaze 7-10), the pH of the water during extraction can be adjusted using known buffers, sodium hydroxide, potassium hydroxide, ammonium hydroxide, etc. good. Although the extraction time is arbitrary, it is usually 1-5 days at room temperature. If the extraction temperature is high, the extraction time will be shortened (for example, 40 - 120 x 0 from 30 minutes to 6 hours)
. In this way, most of the active ingredients contained in the seeds (90% or more in some cases) can be extracted. If desired, a suitable preservative can be added during extraction. Extraction may be continuous or batchwise. The ratio of extraction water to raw material is arbitrary. (For example, the volume of 5-1 of raw materials). If desired, a suitable organic solvent (e.g. methanol, ethanol,
The target product can be easily extracted by removing impurities such as lipids contained in the seeds with one or a mixture of chloroform, ether, hexane, and then extracting with water.
Moreover, the active substance is not destroyed.

外種皮とその内容物とを別々に抽出してもよい。所望に
より、フェノールと水との混合液で種子から活性物質を
抽出することもできる。
The outer seed coat and its contents may be extracted separately. If desired, the active substances can also be extracted from the seeds with a mixture of phenol and water.

この場合フェノールの濃度は、たとえば20−60%と
くに40−50%、温度と時間は任意でよい(たとえば
50−80℃で1ぴ分ないし60分間)。回収 炉過、圧搾または遠心分離のような常法により、抽出液
から植物の磯笹を除去し、こうして得られた抽出液から
低分子物貿、色素等の不活性成分を除き、活性成分を回
収する。
In this case, the concentration of phenol may be, for example, 20-60%, especially 40-50%, and the temperature and time may be arbitrary (eg, 50-80° C. for 1 minute to 60 minutes). The isobasa of the plant is removed from the extract by conventional methods such as recovery furnace filtration, squeezing, or centrifugation, and the inert components such as low molecular weight substances and pigments are removed from the resulting extract, and the active ingredients are removed. to recover.

このため実質的な方法の例は次の通りである。脚 本発
明によるIF誘起活性物質の分子量は約1方以上約20
方以下(主として約2方ないし8方)であるから、たと
えば分画分子量1万以上20方以下(例、2万一8方)
の物質を分別できる適当な膜を用いた限外炉過法で上燈
を処理する。限外炉週の圧力はたとえば0.1−5k9
/仇とすることができる。こうして得られた活性部分を
集めて、凍結乾燥すると白色状の粉末が得られる。
For this purpose, an example of a practical method is as follows. Legs The molecular weight of the IF-inducing active substance according to the present invention is about 1 or more and about 20
(mainly about 2 to 8 directions), for example, the molecular weight cut-off is 10,000 to 20 directions (e.g., 20,000 to 8 directions).
The upper light is treated using an ultrafiltration method using a suitable membrane that can separate the substances. For example, the pressure in an ultra-furnace is 0.1-5k9
/ Can be used as an enemy. The active parts thus obtained are collected and lyophilized to yield a white powder.

フェ/ール/水で抽出した液を限外炉過で分画する場合
には、フェノールや膜を傷つけるおそれのある溶剤を、
透析や減圧のような適当な手法により、限外炉過前に完
全に除去しなければならない。
When fractionating the liquid extracted with phenol/water by ultrafiltration, remove phenol and solvents that may damage the membrane.
It must be completely removed by appropriate techniques such as dialysis or depressurization before passing through the ultrafurnace.

また水で抽出し限外炉過した後、フェノール/水で再抽
出してもよい。【B} 抽出液を所望により減圧下で濃
縮し、親水性有機溶剤(たとえばメタノール、エタノー
ル、ブロパノール、ブタノール、アセトン等)を抽出液
またはその濃縮液に適当な濃度(たとえば40一7ルノ
v%)になるように加えると、活性成分を含む沈殿物が
生じるので、所望によりたとえばセルロースチューブで
透析するか、または減圧下に有機溶媒を除去した後に乾
燥すると、白色状の粉末が得られる。
Alternatively, after extraction with water and filtration in an ultrafurnace, it may be re-extracted with phenol/water. [B} Concentrate the extract under reduced pressure if desired, and add a hydrophilic organic solvent (e.g., methanol, ethanol, propanol, butanol, acetone, etc.) to the extract or its concentrate at an appropriate concentration (e.g., 40-7%). ), a precipitate containing the active ingredient is formed, which can be dialyzed, for example, in a cellulose tube, if desired, or dried after removing the organic solvent under reduced pressure to obtain a white powder.

‘q 上記の有機溶剤の代わりに、塩化アンモニウム、
硫酸アンモニウム、セチルトリメチルアンモニウムプロ
ミドのようなアンモニウム塩または塩化亜塩、塩化鋼の
ような無機金属塩を適当な濃度(たとえば20‐5帆/
v%)になるように加えると、活性成分を含む沈殿物が
生じるので、沈殿物をたとえばセチルロースチューブで
透析するか、分画分子量5000なし、し1万の膜で限
外炉過するかにより脱塩した後乾燥すると、白色状の粉
末が得られる。
'q Instead of the above organic solvent, ammonium chloride,
Ammonium salts such as ammonium sulfate, cetyltrimethylammonium bromide, or inorganic metal salts such as subchloride, steel chloride, at appropriate concentrations (e.g. 20-5 sails/
v%), a precipitate containing the active ingredient will be generated, so the precipitate should be dialyzed, for example, with a cetylulose tube, or filtered in an ultra-furnace through a membrane with a molecular weight cutoff of 5,000 or 10,000. After desalting and drying, a white powder is obtained.

以上のようにして抽出液を処理することによって、原料
中の活性成分の大部分(場合により90%以上)を回収
することができる。
By treating the extract as described above, most of the active ingredients in the raw materials (90% or more in some cases) can be recovered.

しかし、得られた乾燥粗粉末中の不純物の含有量は凶の
方法が最低である。また弧の方法は操作が簡単で費用が
安く短時間に行なうことができる。しかも■の方法で得
られた粗粉末をそのまま動物に多量に経口投与しても著
しい副作用は認められないことがわかつた。精製 本発明の方法で得られる活性物質は水落性の酸性物質で
あるから、この糧の物質の精製に常用される各種の方法
によって精製することができる。
However, the content of impurities in the obtained dry coarse powder is the lowest in the worst method. Furthermore, the arc method is easy to operate, inexpensive, and can be carried out in a short time. Moreover, it was found that no significant side effects were observed even when the crude powder obtained by method (2) was orally administered in large quantities to animals as it was. Purification Since the active substance obtained by the method of the present invention is a water-soluble acidic substance, it can be purified by various methods commonly used for the purification of this food substance.

この粗粉末を、たとえばゲル炉過剤またはイオン交換剤
を用いるカラムクロマトグラフィーのような常法によっ
て精製する。ゲル炉過剤を用いた場合は適当な緩衝液で
溶出してもよいが、通常は水で溶出すればよい。イオン
交換剤を用いた場合は適当な緩衝液で溶出する。実用的
なゲル炉過剤の例は、セフアデックスG−50からG−
200まで、セフアローズ波から脂まで、セフアクリル
S一200またはS一300(スエ−デン国、ファーマ
シア・ファイン・ケミカルAB製)、バイオゲルP−3
0からP−300まで、バイオゲルA(米国、バイオラ
ード・ラボラトリース製)、サガバツク(英国、セラバ
ツク。
This crude powder is purified by conventional methods such as column chromatography using gel filtration or ion exchange agents. When a gel filtration agent is used, elution may be performed with an appropriate buffer, but usually water may be used for elution. If an ion exchange agent is used, elute with an appropriate buffer. Examples of practical gel filter agents are Sephadex G-50 to G-
up to 200, from Cefarrows wave to fat, Cefacryl S-200 or S-300 (manufactured by Pharmacia Fine Chemicals AB, Sweden), Biogel P-3
0 to P-300, Biogel A (manufactured by Biorad Laboratories, USA), Sagaback (Seraback, UK).

ラボラトリース製)等である。イオン交換剤の実用的な
例は、DEAEセフアデツクスA一25およびA一50
(CI‐型)、QAEセフアデツクスA−25およびA
−50(CI‐型)、CMセフアデツクスC−25およ
びC−50(Na+型)、SPセフアデツクスC−25
およびC−50(Na1型)、DEAEセフアセル(C
I‐型)、DEAEセファロースCL一服(CI‐型)
、CMセファロースCL−紐(Na十)(スヱーガン国
、ファーマシア・ファイン・ケミカルAB製)等である
。適当なアニオンまたはカチオンィオン交換セルロース
を用いて粗粉末を精製することもできる。こうして得ら
れるものは、多少の不純物を含んでいるが、IF誘起剤
として用いることができる。所望により、上記の精製工
程を組合わせることによって、不純物をさらに除去する
こともできる。m誘起活性 後記実施例記載の方法で得られた最終産物の試料を用い
て試験動物の細胞および血清中にIFを議起し、その活
性を後記試験例記載の方法で測定した結果は第1表およ
び第2表の通りで、IF議超活性が認められた。
(manufactured by Laboratories), etc. Practical examples of ion exchangers are DEAE Cephadex A-25 and A-50.
(CI-type), QAE Cephadex A-25 and A
-50 (CI-type), CM Cephadex C-25 and C-50 (Na+ type), SP Cephadex C-25
and C-50 (Na1 type), DEAE Cefacel (C
I-type), DEAE Sepharose CL dose (CI-type)
, CM Sepharose CL-string (Na 10) (manufactured by Pharmacia Fine Chemicals AB, Sweden), and the like. The crude powder can also be purified using a suitable anion or cation exchange cellulose. Although the product thus obtained contains some impurities, it can be used as an IF inducer. If desired, impurities can be further removed by combining the above purification steps. m-induced activity IF was induced in the cells and serum of test animals using a sample of the final product obtained by the method described in the Examples below, and the activity was measured by the method described in the Test Examples below. As shown in Table and Table 2, IF hyperactivity was observed.

第1表 IF活性(インピトロ法) 5羽のウサギを用いて、後記試験例記載の方法で実施例
1の最終産物から得た結果は第2表の通りで、5羽とも
に投与後2時間で最大の活性に達した。
Table 1 IF activity (in vitro method) The results obtained from the final product of Example 1 using the method described in the test example below using 5 rabbits are shown in Table 2. Maximum activity reached.

実施例2以下で得られた最終産物の活性値もおよそ同様
であった。第2表 (IF活性、イン・ピボ法、平均値) 次に、下記の実施例において用いたベニバナ等の種子は
日本産であるが、比較のために、下記の外国産ベニバナ
の種子を各実施例記載の方法でそれぞれ処理して得た最
終産物を、後記試験例記載のィンビトo法およびィンビ
ボ法で処理して、び議起試験を行なった結果、日本産ベ
ニバナの結果と有意義な差は認められなかった。
The activity values of the final products obtained in Example 2 and below were also approximately the same. Table 2 (IF activity, in-pivot method, average value) Next, the seeds of safflower etc. used in the following examples are produced in Japan, but for comparison, the following seeds of foreign safflower were used in each case. The final products obtained by each treatment according to the methods described in the examples were treated with the in vitro method and in vivo method described in the test examples below, and the results of a stimulation test showed a significant difference from the results of Japanese safflower. was not recognized.

‘11アメリカ合衆国アリゾナ州Tucson産■ 同
アリゾナ大学産“Oila”{3} 同カルフオルニア
大学(合衆国農務省種苗園産)“PaniaI Hul
l”,“14一5”,“Red肥d 日山1一2”およ
び“01eicLeeが’(4} フランス国パリ、市
販品 ■ インドカルカッタ市販品 後記試験例【a’,‘b}記載のィンピトロ法およびィ
ンビポ法で産生されたIF試料は、同動物種のウサギR
K−1群細胞上で水庖性口内炎ウイルスの増殖を抑制す
る他、ワクシニアウィルス(Vacciniavir瓜
)の増殖も抑制するが、動物種の異なるマウスのL細胞
では水癖性口内炎ウイルス(VSV)の増殖を抑制しな
い。
'11 Produced in Tucson, Arizona, U.S.A. ■ "Oila" from the University of Arizona {3} "PaniaI Hul" from the University of California (produced at the U.S. Department of Agriculture Nursery)
l'', ``14-5'', ``Red Fertilized Hiyama 1-2'' and ``01eicLee'' (4} Paris, France, commercially available product■ Indian Calcutta commercially available product described in the test examples [a','b} below) IF samples produced by in vitro and in vitro methods were tested using rabbit R of the same species.
In addition to suppressing the proliferation of varicella stomatitis virus on K-1 group cells, it also suppresses the proliferation of vaccinia virus (Vaccinia virus), but it inhibits the proliferation of varicella stomatitis virus (VSV) on L cells of mice of different animal species. Do not suppress.

また、0.雌トリプシンを370で2時間作用させると
そのIF活性は失活する。従って、本発明の方法によっ
て生産された活性物質は、広く認められたIF誘起剤の
定義に該当する物質であることが明らかである。前述の
通り、本活性物質は実質的に精製された状態において無
定形白色粉末で、水溶性の酸性物質である。その理化学
的特性はまだ充分に解明されてはいないが、分子量の異
なる点ならびに上記の通り、IF誘起活性が活性物質A
と同等以上である点からみて、活性物質Bは新規のIF
誘起剤であると信じられる。活性物質Bは、ヒトおよび
動物の各種ウイルス感染症の予防および治療剤として有
用であることが期待される。実施例 1 乾燥したベニバナ(Caれhamus tinctm;
uSLin肥)の種子(100夕)を細砕した後、水(
1000叫)中に常温で3日間放置することにより抽出
し、これを遠心処理(loo0ぴ.p.m.、20分間
)して、抽出液と残笹に分け、残澄を水(各500の‘
)で2回洗浄し、洗液を抽出液に合わせた。
Also, 0. When female trypsin is applied at 370°C for 2 hours, its IF activity is inactivated. It is therefore clear that the active substances produced by the method of the invention are substances that fall within the widely accepted definition of IF inducers. As previously mentioned, the active substance is an amorphous white powder in its substantially purified state, and is a water-soluble acidic substance. Although its physicochemical properties have not yet been fully elucidated, it is clear that the IF-induced activity is different from that of the active substance A in terms of their different molecular weights and as mentioned above.
Active substance B is a new IF.
It is believed to be an inducing agent. Active substance B is expected to be useful as a prophylactic and therapeutic agent for various viral infections in humans and animals. Example 1 Dried safflower (Care hamus tinctm;
After crushing the seeds (100 grains) of uSLin fertilizer, water (
The extract was extracted by leaving it at room temperature for 3 days in 1,000 p.m. (1,000 p.m.), centrifuged (20 min. of'
) was washed twice, and the washing liquid was combined with the extract liquid.

こうして得られた抽出液をMC一4A型限外炉過器(バ
イオエンジニアリングK.K.、東京)で、XM−10
山兆辰外炉過膜(分画分子量10方、米国アミコン社製
)を用いて限外炉過(圧力3k9/地)した後、その透
過液をPM■戸過騰(分画分失子量1方、米国アミコン
社製)を用いて、限外炉過した。残留物を集めて凍結乾
燥し、白色粉末(212のo)を得た。この粉末を水(
5の‘)に溶解し、その水溶液をセフアデツクスG−1
00(ファーマシア・フアイン・ケミカルAB、スヱー
デン国)を充填したカラム(4.5×70伽)に添加し
、水(1200の‘)で熔出し、綾出液を各5私の区分
に分け「6G蚤から15伍蚤までの区分を合わせて脱塩
後凍結乾燥し、白色状粉末(55.2雌)を得た。さら
に精製するために、この粉末を0.01Mトリス−塩酸
緩衝液(pH7.0、1=0.01)(5の‘)に溶解
し、DEAEセフアデツクスA−50(フアーマシア・
ファイン・ケミカルAB、スエーデン国)を充填したカ
ラム(2.5×70仇)に添加し、0.2Mトリスー塩
酸緩衝液(冊8.6:0.8M食塩を含む、500肌)
で溶出し、溶出液を各5の‘の区分に分け、2疎蚤から
4項客までの区分を合わせた。この溶液をFM−10限
外炉過膜(分画分子量1方、米国アミコン社製)を用い
た限外炉週により脱塩後、凍結乾燥し、不定形な白色状
粉末(斑.lmo)を得た。これを第1の白色状粉末と
比べると、IF謎超活性が高まった。実施例 2 乾燥したベニバナの種子(100夕)を細砕し、水(1
000似)を加え、10ぴ0で60分間抽出した後、抽
出液を実施例1記載の方法に準じて処理し、白色粉末(
41.2雌)を得た。
The extract obtained in this way was passed through an MC-4A ultrafilter (Bio Engineering K.K., Tokyo) using an XM-10
After ultrafiltration (pressure 3k9/earth) using a Yamachoshin outer furnace filtration membrane (molecular weight cutoff 10, manufactured by Amicon, USA), the permeate was subjected to PM The mixture was subjected to ultrafilter filtration using an ultrafiltration filter (manufactured by Amicon, USA). The residue was collected and lyophilized to obtain a white powder (212 o). Add this powder to water (
5'), and the aqueous solution was added to Sephadex G-1.
00 (Pharmacia Fine Chemical AB, Sweden) was added to a column (4.5 x 70) packed with water (1200 mm), and the lysate was divided into 5 sections each. A white powder (55.2 females) was obtained by desalting and lyophilizing the 6G to 15G flea.For further purification, this powder was added to 0.01M Tris-HCl buffer. (pH 7.0, 1=0.01) (5'), DEAE Sephadex A-50 (Pharmacia
Fine Chemicals AB, Sweden) was added to a column (2.5 x 70 cells) packed with 0.2M Tris-HCl buffer (Book 8.6: 500 cells containing 0.8M salt).
The eluate was divided into 5 categories, and the categories from 2 to 4 were combined. This solution was desalted in an ultrafilter using an FM-10 ultrafilter membrane (molecular weight cut off: 1, manufactured by Amicon, USA), and then lyophilized to produce an amorphous white powder (spotted.lmo). I got it. When this was compared with the first white powder, the IF mystery superactivity was increased. Example 2 Dried safflower seeds (100 seeds) were crushed and mixed with water (100 seeds).
After extracting for 60 minutes at 10 μm, the extract was treated according to the method described in Example 1 to obtain a white powder (
41.2 females) were obtained.

実施例 3 乾燥したベニバナの種子(100夕)を細砕し、水(1
000M)を加え、120ooで60分間オ−トクレー
ブ(1気圧)で抽出した他、実施例1記載の方法に準じ
て処理し、白色粉末(43.4のo)を得た。
Example 3 Dried safflower seeds (100 seeds) were crushed and mixed with water (100 seeds).
000 M) was added and extracted in an autoclave (1 atm) at 120 oo for 60 minutes, and the mixture was treated according to the method described in Example 1 to obtain a white powder (43.4 o).

実施例 4乾燥したベニバナの種子(100夕)を細砕
し、アセトン(500の‘)で4℃で一夜放置した後、
抽出液を炉紙で炉過して、務澄を得た。
Example 4 Dried safflower seeds (100 min) were crushed and left in acetone (500 min) overnight at 4°C.
The extract was filtered through furnace paper to obtain Muzumi.

この礎澄にアセトン(500の‘)を加えて60分間振
とう抽出し、抽出液を炉紙で炉過して浅漬を得た。同様
のアセトン振とう抽出を5回くり返して得た残澄を減圧
下に乾燥してアセトンを除き、水(l000叫)を加え
、実施例1記載の方法に準じて処理し、白色粉末(44
.6雌)を得た。実施例 5 アセトンの代わりにクロロホルムノメタノール混合液(
500の‘;1:lv/v)を用いた他、実施例4と同
様の方法によって処理し、白色粉末(30のp)を得た
Acetone (500 ml) was added to this base liquid and extracted by shaking for 60 minutes, and the extract was filtered through furnace paper to obtain pickled vegetables. The same acetone-shaking extraction was repeated five times, and the resulting residue was dried under reduced pressure to remove acetone, water (1,000 ml) was added, and the solution was treated according to the method described in Example 1 to produce a white powder (44 ml).
.. 6 females) were obtained. Example 5 Chloroformomethanol mixture (
A white powder (30 p) was obtained by treatment in the same manner as in Example 4 except that 500'; 1:lv/v) was used.

実施例 6 ベニバナの種子(100夕)を圧搾器で絞りその残澄に
水(1000の【)を加え、10ぴ0で60分間加熱抽
出し、実施例1記載の方法に準じて処理し、白色粉末(
37.6のo)を得た。
Example 6 Safflower seeds (100 g) were squeezed with a press, and water (1000 g) was added to the residue, heated and extracted at 10 pg for 60 minutes, and treated according to the method described in Example 1. white powder (
o) of 37.6 was obtained.

実施例 7 アレチベニバナの種子(100夕)を細砕し、水(50
0凧‘)を加え、筋℃に加熱後、68qoの90%フェ
ノール溶液(500の【)を加え、かくはんしながら2
び分間抽出した。
Example 7 Seeds of safflower (100 grains) were crushed and mixed with water (50 grains).
0 Kite') was added and heated to a temperature of 100°C, then 68 qo of 90% phenol solution (500 Kite') was added, and while stirring,
The mixture was extracted for several minutes.

これを室温まで冷却後、遠心処理し(700仇.p.m
.;20分間)水層(上層)フェノール層(中間層、下
層)残澄に分離した。水層部分を回収した。残りのフェ
ノール層と残11との混合部分にさらに水400の1を
加え;68℃で20分間再抽出した。このときの水層部
分を回収し、さきの水層部分に合し、セルロースチュー
ブに入れ、4℃で3日間イオン交換水で透析した。その
後に実施例1記載の方法に準じて処理し;白色粉末(2
50のp)を得た。試験例 1 IF誘起法およびIF活性測定法(参考文献:Y.Ko
jima,Kiねsato Arch.,E×p.,M
ed,.43:351970)‘aーイン・ピトロ法に
よるmの譲起方法ウサギ(体重約lk9、ニュージーラ
ンドホワイト種、SPF)を全採血して殺し、際豚、骨
髄およびリンパ節細胞を採取し、子牛血清10%を含む
イーグルMEM培地(日水製薬製)を用いて混合細胞1
07/の‘を含む細胞浮遊液をつくり、各浮遊液区分(
1の‘)に、本発明の製造例1記載の法で得られたm譲
超剤10,1,0.1,0.01ムタ/の‘をそれぞれ
加え、25午○で2独時間培養後、各培養液を遠心処理
してその上澄液をとり、び活性測定用に供した。
After cooling this to room temperature, it was centrifuged (700 m.p.m.
.. ; 20 minutes) was separated into an aqueous layer (upper layer), a phenol layer (middle layer, lower layer) and a residual liquid. The aqueous layer portion was collected. Another 400 parts of water was added to the mixed portion of the remaining phenol layer and Residue 11; the mixture was re-extracted at 68°C for 20 minutes. The aqueous layer at this time was collected, combined with the previous aqueous layer, placed in a cellulose tube, and dialyzed against ion-exchanged water at 4°C for 3 days. Thereafter, it was treated according to the method described in Example 1; white powder (2
50 p) were obtained. Test Example 1 IF induction method and IF activity measurement method (Reference: Y.Ko
jima, Kinesato Arch. , E×p. ,M
ed,. 43:351970) 'Ain Pitro Method for Generating M Rabbits (weighing approximately lk9, New Zealand White breed, SPF) were sacrificed by exsanguination, bone marrow and lymph node cells were collected, and calf serum was collected. Mixed cells 1 using Eagle MEM medium (manufactured by Nissui Pharmaceutical Co., Ltd.) containing 10%
Make a cell suspension containing '07/' and divide each suspension section (
1') were added with 10, 1, 0.1, and 0.01 muta/' of the m-transfer agent obtained by the method described in Production Example 1 of the present invention, respectively, and cultured at 25 o'clock for 2 hours. Thereafter, each culture solution was centrifuged, and the supernatant was collected and used for measurement of activity.

‘b}ィン・ピポ法によるびの譲超方法 製造例1記載の法で得られた『誘起剤の水溶液(500
ムタ/の【)2Mをウサギ(体重約lk9、ニュ−ジラ
ンドホワイト種、SPF)の耳静脈に注射し、1,2,
4,6時間後に採血(2の上)し、その血清をび活性測
定用に供した。
'b} Aqueous solution of inducer (500%
Muta/'s [) 2M was injected into the ear vein of a rabbit (weight approximately lk9, New Zealand White breed, SPF), and 1,2,
After 4 and 6 hours, blood was collected (above 2), and the serum was used for the measurement of anti-inflammatory activity.

{C血清性の測定 上記【幻,‘b’法ともに、産生されたm活性の測定は
、ウサギ賢株化細胞(RK−13)を用いた50%ブラ
ック半減法で行なわれる。
{Measurement of C serum activity In both the above-mentioned phantom and 'b' methods, the produced m activity is measured by the 50% black half-life method using rabbit Ken cell line (RK-13).

Claims (1)

【特許請求の範囲】 1 キク料(Compositae)ベニバナ属(Ca
rthamus)に属しかつインターフエロン誘起活性
物質を含有する植物またはその変員の組織から上記活性
物質を抽出し、抽出物からこれを回収する工程からなる
インターフエロン誘起剤の製法において、組織として種
子を用いることを特徴とする方法。 2 水で抽出する特許請求範囲1による方法。 3 水とフエノールとの混合液で抽出する特許請求範囲
1による方法。 4 抽出液に親水性有機溶剤を加えることにより活性物
質を回収する特許請求の範囲1から3までのどれかによ
る方法。 5 抽出液にアンモニウム塩または無機金属塩を加える
ことにより活性物質を回収する特許請求範囲1から3ま
でのどれかによる方法。 6 キク料(Compositae)ベニバナ属(Ca
rthamus)に属しかつインターフエロン誘起活性
物質を含有する植物またはその変員の組織から上記活性
物質を抽出し、抽出物からこれを回収する工程からなる
インターフエロン誘起剤の製法において、種子に含有さ
れた上記活性物質を水で抽出し、抽出液から限外濾過に
よって活性物質を回収することを特徴とするインターフ
エロン誘起剤の製法。 7 フエノールを含む水で抽出し、抽出液からフエノー
ル分を除去した後限外濾過する特許請求範囲第6項によ
る方法。 8 限外濾過により、分子量約1万ないし約20万、主
として約2万ないし約8万の抽出物を分別する特許請求
範囲第6または7項による方法。 9 プレスされた種子を用いる特許請求範囲1から8ま
でのどれかによる方法。 10 脱脂された種子を用いる特許請求範囲1から9ま
でのどれかによる方法。 11 有機溶剤で脱脂された種子を用いる特許請求範囲
10による方法。 12 プレス後に有機溶剤で脱脂された種子を用いる特
許請求範囲10による方法。
[Scope of Claims] 1. Compositae, Safflower genus (Ca.
In the method for producing an interferon inducer, which comprises the steps of extracting the active substance from the tissue of a plant or a variant thereof belonging to P. rthamus and containing the interferon-inducing active substance, and recovering it from the extract, seeds are used as the tissue. A method characterized by using 2. The method according to claim 1, which involves extraction with water. 3. The method according to claim 1, which involves extraction with a mixture of water and phenol. 4. A method according to any one of claims 1 to 3, in which the active substance is recovered by adding a hydrophilic organic solvent to the extract. 5. A method according to any one of claims 1 to 3, in which the active substance is recovered by adding an ammonium salt or an inorganic metal salt to the extract. 6 Compositae, Safflower (Ca
rthamus) and containing the interferon-inducing active substance from the tissue of a plant or its variant, and recovering the active substance from the extract. A method for producing an interferon inducer, which comprises extracting the above-mentioned active substance with water and recovering the active substance from the extract by ultrafiltration. 7. The method according to claim 6, which comprises extracting with water containing phenol, removing the phenol from the extract, and then ultrafiltrating. 8. The method according to claim 6 or 7, in which an extract having a molecular weight of about 10,000 to about 200,000, mainly about 20,000 to about 80,000, is fractionated by ultrafiltration. 9. A method according to any one of claims 1 to 8 using pressed seeds. 10. A method according to any one of claims 1 to 9 using defatted seeds. 11. A method according to claim 10 using seeds defatted with an organic solvent. 12. The method according to claim 10, using seeds that have been defatted with an organic solvent after pressing.
JP55107955A 1980-08-06 1980-08-06 Production method of interferon inducer Expired JPS6013004B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP55107955A JPS6013004B2 (en) 1980-08-06 1980-08-06 Production method of interferon inducer
GB8123976A GB2082187B (en) 1980-08-06 1981-08-05 Interferon inducers extracted from carthamus
US06/290,283 US4440761A (en) 1980-08-06 1981-08-06 Interferon inducer, a process for producing the same and pharmaceutical composition containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55107955A JPS6013004B2 (en) 1980-08-06 1980-08-06 Production method of interferon inducer

Publications (2)

Publication Number Publication Date
JPS5732223A JPS5732223A (en) 1982-02-20
JPS6013004B2 true JPS6013004B2 (en) 1985-04-04

Family

ID=14472289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55107955A Expired JPS6013004B2 (en) 1980-08-06 1980-08-06 Production method of interferon inducer

Country Status (3)

Country Link
US (1) US4440761A (en)
JP (1) JPS6013004B2 (en)
GB (1) GB2082187B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742046A (en) * 1984-08-03 1988-05-03 Medisearch S.A. Methods and compositions for inhibiting the infectious activity of viruses
JPH0198708A (en) * 1987-10-07 1989-04-17 Ebara Res Co Ltd Radial magnetic bearing device
GB9219905D0 (en) * 1992-09-19 1992-11-04 Univ Liverpool Lectins
GB9608145D0 (en) * 1996-04-19 1996-06-26 British Tech Group Wound healing

Also Published As

Publication number Publication date
GB2082187B (en) 1983-12-07
US4440761A (en) 1984-04-03
GB2082187A (en) 1982-03-03
JPS5732223A (en) 1982-02-20

Similar Documents

Publication Publication Date Title
EP0030444B1 (en) A process for preparing substances having interferon inducing activity
CA2232294C (en) Bioactive factors of aloe vera plants
JP7471393B2 (en) Tea composition having preventive or ameliorative effects on respiratory diseases and pharmaceutical composition containing the same
DK145505B (en) PROCEDURE FOR PREPARING A NITROGEN CONTAINING POLYSACCHARIDE
DE2655844C3 (en) Process for the production of anti-tumor substances
EP0030812B1 (en) A process for preparing substances having interferon inducing activity and interferon inducers
US4793996A (en) Method of making soybean extract inhibitor
AU2002342778A1 (en) Solvent extraction process
EP1430073A1 (en) Solvent extraction process
EP0202275B1 (en) Skin regenerating cosmetic composition
EP0040641B1 (en) Process for isolating and purifying a fraction capable of inhibiting mutagenicity of a mutagenic material from burdock juice
JPS6013004B2 (en) Production method of interferon inducer
CN108158912B (en) Silybum marianum gel for removing acne and repairing scars and preparation method thereof
JPH10506124A (en) COMPOSITION HAVING ANTIVIRUS PROPERTIES AND PROCESS FOR PRODUCING THE SAME
US4861761A (en) Aloeferon isolation, manufacturing and its applications
JPH0449240A (en) Antipeptic ulcer agent and antipeptic ulcer agent for animal
JP4050560B2 (en) Vascular endothelial growth factor production promoter
US4456597A (en) Interferon inducer, a process for producing the same and pharmaceutical composition containing the same
EP0595297A1 (en) Lignin polymer composition for the treatment of skin problems
DE2553971A1 (en) SUBSTANCE WITH ANTIVIRAL ACTIVITY, PROCEDURE FOR ITS MANUFACTURING AND ITS THERAPEUTIC USE
CH640865A5 (en) GLYCOPROTEIDE OF HUMAN URINE, METHOD FOR THE PRODUCTION THEREOF AND MEANS FOR COMBATING LEUKOCYTOPENIA.
DE3004018C2 (en)
CN115462530B (en) Chestnut kernel extract, extraction method thereof and application thereof in antioxidant products
JPS61209599A (en) Production of polysaccharide by tissue culture
KR20050097698A (en) A method for producing oleanolic acid and ursolic acid from persimmon peel